The Lasting Impact of COVID-19 on Drug Development

This session was originally broadcast live on 3rd August 2021

A disrupter event to many business and industries worldwide, what lasting impacts will be felt and what can pharma learn from the COVID-19 pandemic in terms of the acceleration of drug development and repurposing in the future; the broader impact on how trials are conducted, and the impact of virtual clinical trials for clinical supplies business.  
 

Discussion Points: 

· Fast-tracking R&D 

· Emergency use approvals 

· Drug Repurposing 

· Diversifying Clinical trials